As a matter of fact, the expression of these miRNAs resensitize MM cells to chemotherapy [35,36,37,38,39,40]; finally miRNA-34a was also positively correlated with wild type p53 function with particular actions on MM cell survival [41]. This evidence concerns the gene TP53 and Miyoshi myopathy.